Cancer Advances
Subscribe:
Featured Episode
Rethinking Pediatric Hodgkin Lymphoma Care
The Cancer Advances Podcast is joined by the Chair of the Division of Pediatric Hematology Oncology and Director of the Bone Marrow Transplant Program, Rabi Hanna, MD, along with Ilia Buhtoiarov, MD, a physician at the Division of Pediatric Hematology Oncology leading the Leukemia Lymphoma Program to discuss evolving approaches to treating pediatric Hodgkin lymphoma. Listen as they talk about how novel therapies, including checkpoint inhibitors and PET-guided treatment strategies, are reshaping patient care and help avoid the need for bone marrow transplant.
Play NowAll Cancer Advances Episodes
April 10, 2025
Molecular Insights into Early-Onset Biliary Tract Cancer
Alok Khorana, MD, Director of the Gastrointestinal Malignancies Program at Cleveland Clinic Cancer Institute, joins the Cancer Advances Podcast to break down the latest research on early-onset biliary tract cancer, diving into the genetic and molecular differences that set it apart. Listen as Dr. Khorana addresses the challenges in diagnosing and treating this cancer and the exciting potential for personalized therapies tailored to these molecular discoveries.
Play NowApril 3, 2025
Advances in Treating Mandibular Osteoradionecrosis
Michael Fritz, MD, Director of the Section of Facial Plastic and Reconstructive Surgery at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the approaches to the classification and management of mandibular osteoradionecrosis (ORN). Listen as Dr. Fritz shares insights into the classification and treatment of ORN, including the role of PENTO therapy and the groundbreaking anterolateral thigh rescue flap technique, highlighting the importance of early intervention and how multidisciplinary collaboration can improve patient outcomes.
Play NowMarch 27, 2025
Advancing Multiple Myeloma Treatment
The Cancer Advances podcast is joined by hematologists Sandra Mazzoni, DO and Shahzad Raza, MD to discuss the latest advancements in multiple myeloma treatment. Listen as they explore the evolving role of CAR-T cell therapy, bispecific antibodies, and autologous stem cell transplants and how they are changing the multiple myeloma treatment landscape.
Play NowMarch 20, 2025
The MiDe Study’s Approach to Predict, Prevent and Detect Ovarian Cancer
Kevin Elias, MD, the Lilli and Seth Harris Endowed Chair for Ovarian Cancer at Cleveland Clinic, joins the Cancer Advances podcast to discuss the challenges of trying to detect ovarian cancer early and the need for better predictive tools. Listen as Dr. Elias talks about the MiDe Study, which aims to identify high-risk women through microRNA-based blood tests, potentially transforming ovarian cancer screening and prevention.
Play Now
